Frequent basal cell cancer development is a clinical marker for inherited cancer susceptibility
- DOI
- 10.1172/jci.insight.122744
- Published
- 2018-08-09
- Container
- JCI Insight
- Publisher
- American Society for Clinical Investigation
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1172/jci.insight.122744,
title = {Frequent basal cell cancer development is a clinical marker for inherited cancer susceptibility},
author = {Hyunje G. Cho and Karen Y. Kuo and Shufeng Li and Irene Bailey and Sumaira Aasi and Anne Lynn S. Chang and Anthony E. Oro and Jean Y. Tang and Kavita Y. Sarin},
year = {2018},
journal = {JCI Insight},
doi = {10.1172/jci.insight.122744},
url = {https://doi.org/10.1172/jci.insight.122744}
}RIS
TY - JOUR TI - Frequent basal cell cancer development is a clinical marker for inherited cancer susceptibility AU - Hyunje G. Cho AU - Karen Y. Kuo AU - Shufeng Li AU - Irene Bailey AU - Sumaira Aasi AU - Anne Lynn S. Chang AU - Anthony E. Oro AU - Jean Y. Tang AU - Kavita Y. Sarin PY - 2018 JO - JCI Insight DO - 10.1172/jci.insight.122744 UR - https://doi.org/10.1172/jci.insight.122744 ER -
APA
Cho, H. G., Kuo, K. Y., Li, S., Bailey, I., Aasi, S., Chang, A. L. S., Oro, A. E., Tang, J. Y., & Sarin, K. Y. (2018). Frequent basal cell cancer development is a clinical marker for inherited cancer susceptibility. JCI Insight. https://doi.org/10.1172/jci.insight.122744
Source records
- crossref · retrieved 2026-09-27T12:21:04.789Z